ANNE BATES LEACH EYE HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.3M
- Transactions
- 190
- Companies
- 20
- Average per transaction
- $7,047
Who reported the payments
| Regeneron | $418,500 |
| Incyte Corporation | $356,590 |
| Johnson & Johnson Surgical Vision, Inc. | $197,500 |
| Janssen Research & Development, LLC | $108,631 |
| Regeneron Healthcare Solutions, Inc. | $34,000 |
| AbbVie | $33,500 |
| Alcon | $32,500 |
| Novartis | $30,796 |
| Carl Zeiss Meditec, Inc. | $26,000 |
| Carl Zeiss Meditec USA, Inc. | $25,176 |
| Janssen Global Services, LLC | $20,000 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $20,000 |
| Qiagen, LLC | $18,990 |
| Mindray DS USA, Inc. | $7,745 |
| Genentech USA, Inc. | $3,500 |
| Shire North American Group Inc | $3,500 |
| Fisher Scientific Company L.L.C. | $1,141 |
| E.r. Squibb & Sons, L.L.C. | $556 |
| Stryker | $201 |
| Johnson & Johnson Vision Care, Inc. | $38 |